PRCT PROCEPT BioRobotics Corp Forecast, Technical & Fundamental Analysis
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology... Show more
PRCT is expected to report earnings to fall 182.70% to -46 cents per share on August 04
Q2'26
Est.
$-0.46
Q1'26
Beat
by $1.12
Q4'25
Missed
by $0.21
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.06
The last earnings report on April 29 showed earnings per share of 56 cents, beating the estimate of -56 cents. With 627.71K shares outstanding, the current market capitalization sits at 1.06B.
A.I.dvisor indicates that over the last year, PRCT has been loosely correlated with TNDM. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PRCT jumps, then TNDM could also see price increases.
PRCT's RSI Indicator ascends from oversold territory
The RSI Indicator for PRCT moved out of oversold territory on July 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In of the 35 cases the stock moved higher. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where PRCT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PRCT just turned positive on July 29, 2026. Looking at past instances where PRCT's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRCT advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on July 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PRCT as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for PRCT entered a downward trend on July 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.049) is normal, around the industry mean (10.948). P/E Ratio (0.000) is within average values for comparable stocks, (63.950). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.043). PRCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.235) is also within normal values, averaging (35.779).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PRCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
